Any digs in this??????
About REGN-COV2
REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and
REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus
that causes COVID-19.
To develop REGN-COV2, Regeneron scientists evaluated thousands of fully-human
antibodies produced by the company's VelocImmune® mice, which have been genetically
modified to have a human immune system, as well as antibodies identified from humans
who have recovered from COVID-19. The two potent, virus-neutralizing antibodies that
form REGN-COV2 bind non-competitively to the critical receptor binding domain of the
virus's spike protein, which diminishes the ability of mutant viruses to escape treatment and
protects against spike variants that have arisen in the human population, as detailed